Ascendis Pharma (ASND) PT Raised to $94 at Cowen
Tweet
Share
E-mailGet Alerts ASND Hot Sheet
Price: $253.29 --0%
Rating Summary:
22 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 4 | New: 41
Rating Summary:
22 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 4 | New: 41
Join SI Premium – FREE
Cowen analyst Yaron Werber raised the price target on Ascendis Pharma (NASDAQ: ASND) to $94.00 (from $84.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- Barclays Downgrades Unite Group (UTG:LN) to Underweight
- Barclays Upgrades Safestore Holdings Plc. (SAFE:LN) to Overweight
- Glencore Plc (GLEN:LN) (GLCNF) PT Raised to GBP6 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
